Cardiologs has announced the beginning of a new clinical trial that will involve monitoring the cardiac health of COVID-19 patients being treated with hydroxychloroquine and azithromycin.

For champions of AI in healthcare, the COVID-19 crisis affords an unignorable opportunity to trumpet the technology’s current contributions while directing attention to its potential for helping fight public-health crises to come.

Glioma patients typically need a biopsy so physicians can make a treatment decision, but researchers have developed a new AI algorithm that could make such biopsies unnecessary. 

Researchers in Israel are working to develop a new AI-powered COVID-19 test—and they think it could be especially effective at detecting individuals who carry the virus without showing any symptoms.

Researchers have used computational modeling and a machine-learning approach to predict electrotoxicity in the heart “from the atom to the rhythm.”

According to the company, its newly approved AI model can play a role in helping hospitals triage patients with suspected COVID-19.

Intermountain Healthcare, the sprawling 24-hospital system based in Utah, is partnering with a supplier of healthcare-specific virtual assistants to offer patients an automated COVID-19 interface on Intermountain’s homepage.

Last week Apple and Google jointly announced a Bluetooth platform for tracing contacts of people testing positive with COVID-19. The tech world has been buzzing ever since.